Is relaxation exercise therapy effective in the management of patients with severe arterial hypertension?

Olga D Lebedeva, Abduahat A Achilov, Zilola F Mavlyanova, Alexey V Baranov, Shachnosa A Achilova, Natalia P Sanina, Anatoly D Fesyun, Andrey P Rachin, Maxim Yu Yakovlev, Kirill V Terentev, Igor V Reverchuk, Alie S Velilyaeva, Maria Chiara Maccarone, Stefano Masiero, Olga D Lebedeva, Abduahat A Achilov, Zilola F Mavlyanova, Alexey V Baranov, Shachnosa A Achilova, Natalia P Sanina, Anatoly D Fesyun, Andrey P Rachin, Maxim Yu Yakovlev, Kirill V Terentev, Igor V Reverchuk, Alie S Velilyaeva, Maria Chiara Maccarone, Stefano Masiero

Abstract

Arterial hypertension (AH) is a burning problem in the world. Antihypertensive pharmacological therapy combined by physical exercises is well-studied in patients with mild and moderate AH. However, studies that have investigated relaxation in patients with severe AH in addition to drug therapy are lacking. Optimization of a comprehensive treatment for patients with severe AH, by using a multicomponent rational antihypertensive pharmacotherapy (PT) with subsequent application of relaxation exercise therapy (RET). The study involved 32 male patients with severe AH. Initially, clinical-instrumental and laboratory examination, blood pressure registration and daily arterial blood pressure monitoring were carried out. Suitable PT was selected for all the patients. 3 months after starting PT the patients were divided in 2 groups. The patients of the 1st group were prescribed RET in addition to PT. The 2nd group of patients continued receiving PT alone. 3 months later, average daily blood pressure (ADBP)-syst and ADBP-diast were compared in both groups. Three months after PT both groups demonstrated a significant decrease in ADBP-syst and ADBP diast, but these indicators remained higher than normal and did not reach the target level. Three months after the inclusion of RET in the comprehensive treatment, the 1st group demonstrated a significant decrease in ADBP (systolic and diastolic), not only in comparison with the initial data, but also with the data observed three months after PT. After 6 months, ADBP-syst and ADBP-diast in the 1st group were significantly lower compared with those of patients in the 2nd group. The inclusion of RET in addition to a multicomponent antihypertensive PT is a promising treatment option for severe AH.

Conflict of interest statement

We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Figures

Fig 1.
Fig 1.
CONSORT 2010 Flow Diagram. Note: PT pharmacotherapy; RET relaxation exercise therapy.

References

    1. Xia N, Li H. The role of perivascular adipose tissue in obesity-induced vascular dysfunction. Br J Pharmacol. 2017; 174(20): 3425-3442. doi: 10.1111 / bph.13650.
    1. Ramalingam L, Menikdiwela K, LeMieux M, Dufour JM, Kaur G, Kalupahana N, Moustaid-Moussa N. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance. Biochim Biophys Acta Mol Basis Dis. 2017. May;1863(5):1106-1114. doi: 10.1016/j.bbadis.2016.07.019. Epub 2016 Aug 4..
    1. Aronov DM. History of cardiac rehabilitation in Russia. Kardiologiia. 2018;58(11S):14-21. doi: 10.18087/cardio.2604. (In Russ.).
    1. Kontsevaya AV, Romanenko TS, Vygodin V, Fiitilev S.B. Pharmacoepidemiology and effectiveness of antihypertensive therapy in the specialized cardiological institution clinical practice. Rational pharmacotherapy in cardiology. 2015; 11(1):8-17. doi: 10.20996/1819-6446-2015-11-18-17.(In Russ.).
    1. Aronov DM, Kozlova LV, Bubnova MG. Current state and problems of cardiac rehabilitation in Russia. Cardiosomatics. 2017; 8(3):5–9. doi: 10.26442/2221-7185_8.3.5-9. (In Russ.).
    1. Bubnova MG, Aronov DM. Cardiac rehabilitation: stages, principles and international classification of functioning (ICF). Preventive medicine. 2020;23(5):40-49. doi: 10.17116/profmed2020230 5140.
    1. Chazova IE, Aksenova AV, Oshchepkova EV. Features of the course of arterial hypertension in men and women (according to the national register of arterial hypertension). Therapeutic archive. 2019. Vol 91 No. 1. pp. 4-12. doi: 10.26442/ 00403660.2019.01.000021.
    1. Cataldi M, di Geronimo O, Trio R, Scotti A, Memoli A, Capone D, Guida B. Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy. BMC Pharmacol Toxicol. 2016; 17:9. doi: 10.1186/s40360-016-0055-z.
    1. Jordan J. Pathophysiology of hypertension: what are our current concepts? Internist 2015; 56:219–223. doi: 10.1007/s00108-014-3572-0.
    1. Kario K, Thijs L, Staessen JA. Blood Pressure Measurement and Treatment Decisions. Circ Res. 2019. Mar 29;124(7):990-1008. doi: 10.1161/CIRCRESAHA.118.313219.
    1. Kobayashi K, Sato K, Hatori N, Miyakawa M. A questionnaire survey of general practitioners in Japan's Kanagawa Prefecture for the Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014. ClinExpHypertens. 2017;39(8):705-710. doi: 10.1080/10641963.2017.1313852.
    1. Tocci G., Cicero AF, Salvetti M, Musumeci MB, Ferrucci A, Borghi C, Volpe M. Attitudes and preferences for the clinical management of hypertension and hypertension-related cerebrovascular disease in the general practice: results of the Italian hypertension and brain survey. Clin Hypertens. 2017;23:10. doi: 10.1186/s40885-017-0066-0.
    1. Wermelt JA, Schunkert H. Management der arteriellen Hypertonie [Management of arterial hypertension]. Herz, 2017; 42(5), 515–526. doi:10.1007/s00059-017-4574-1.
    1. Di Daniele N. Therapeutic approaches of uncomplicated arterial hypertension in patients with COPD. Pulm Pharmacol Ther. 2015; 35:1-7. doi:10.1016/j.pupt.2015.09.004.
    1. Mishina IE, Sarana A., Mikhailovskaya TV, Ivanova G. E. Principles of appointment of aerobic physical training during outpatient cardiac rehabilitation / Bulletin of rehabilitation medicine. 2020. No. 3(97). pp. 83-95. doi: 10.38025/2078-1962-2020-97-3-83-95. (In Russ.).
    1. Miroshnikov AB, Smolensky AV, Formenov AD. New possibilities of physical rehabilitation of athletes of power sports with essential hypertension: a randomized controlled study. Bulletin of rehabilitation Medicine. 2020. No. 3(97). pp. 76-82. doi: 10.38025/2078-1962-2020-97-3-76-82. (In Russ.).
    1. Kulchitskaya DB, Kolbasova SN. Non-drug methods of treatment of patients with arterial hypertension / Bulletin of rehabilitation med. 2020. No. 3(97). pp. 65-68 doi: 10.38025/2078-1962-2020-97-3-65-68. (In Russ).
    1. Oganov RG, Shalnova SA, Maslennikova GYa. Epidemiology and prevention of cardiovascular diseases. Cardiology: national guidebook / edited by E. V. Shlyakhto. - 2nd edition, revised and enlarged - M.: GEOTAR-Media, 2019, pp. 173-195. (In Russ.).
    1. Boytsov SA, Balanova YuA, Shalnova SA, Deyev AD, Artamonova GV, Gatagonova TM, Duplyakov DV, Efanov AYu. Arterial hypertension among individuals of 25–64 years of age: prevalence, awareness, treatment and control. Adapted from the materials of ESSE. Cardiovascular therapy and prevention. 2014;4;4-14. doi:10.15829/1728-8800-2014-4-4-14. (In Russ.).
    1. Muromtseva GA, Kontsevaya A.V, Konstantinov, Artamonova GV, Gatagonova TM, Duplyakov D V, Efanov A. Yu. The prevalence of non-infectious diseases risk factors in the Russian population in 2012-2013. the results of ESSE-RF. Cardiovascular therapy and prevention. 2014;13(6): 4-11. doi: 10.15829/1728-8800-2014-6-4-11. (In Russ.)
    1. Papathanasiou J, Troev T, Ferreira AS, Tsekoura D, Elkova H, Kyriopoulos E, Ilieva E. Advanced Role and Field of Competence of the Physical and Rehabilitation Medicine Specialist in Contemporary Cardiac Rehabilitation. Hellenic J Cardiol. 2016;57(1):16-22. doi:10.1016/s1109-9666(16)30013-6.
    1. Troev T, Papathanasiou J. Essentials of Physical and Rehabilitation Medicine for Undergraduate Medical Students. 1st edn. Lax Book. 2016; ISBN 978-619-189-041-5.
    1. Papathanasiou JV, Ilieva EM, Nikolov FP. Exercise training modes in rehabilitation of patients with chronic heart failure. Folia Med (Plovdiv). 2012;54(4):22-28. doi:10.2478/v101 53-012-0002-8.
    1. Achilov AA. Method of prevention, treatment and regression of hypertension, atherosclerosis, coronary heart disease, circulatory failure. Patent for the invention EN 2245700 C2, 10.02.2005. Application No. 2002123235/14 of 29.08.2002.
    1. Achilov AA. Method for unloading the heart, increasing blood flow, restoring and preserving the reserve and general exchange surface of capillaries in various areas of the body at the level of regional hemodynamics. Eurasian patent No. 004621 of 24.06.2004.
    1. Chazova IE, Zhernakova YuV. Clinical guidelines. Diagnosis and treatment of arterial hypertension. [Guidelines]. Systemic Hypertension. 2019; 16(1):6–31. doi: 10.26442/2075082X.2019.1.190179. (In Russ.).
    1. Kobalava ZhD, Konradi AO, Nedogoda SV. Arterial hypertension in adults. Clinical guidelines 2020. Russian journal of cardiology. 2020; 25(3):149-218. doi: 10.15829/1560-4071-2020-3-3786 (In Russ.).
    1. Naci H, Salcher-Konrad M, Dias S, Blum MR, Sahoo SA, Nunan D, Ioannidis JPA. How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure. Br J Sports Med. 2019. Jul;53(14):859-869. doi: 10.1136/bjsports-2018-099921. Epub 2018 Dec 18..
    1. Saco-Ledo G, Valenzuela PL, Ruiz-Hurtado G, Ruilope LM, Lucia A. Exercise Reduces Ambulatory Blood Pressure in Patients With Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2020; 9(24), e018487. doi:10.1161/JAHA.120.018487.
    1. Boutcher YN, Boutcher SH. Exercise intensity and hypertension: what's new? Journal of human hypertension. 2017; 31(3), 157–164. doi:10.1038/ jhh.2016.62.
    1. Ribeiro F. Resistance exercise for the management of arterial hypertension: An intervention that works!. Journal of clinical hypertension (Greenwich, Conn.), 2021; 23(5), 987–989. doi:10.1111/jch.14197.
    1. Polegato BF, Paiva SAR. Hypertension and Exercise: A Search for Mechanisms. Arq Bras Cardiol. 2018;111(2):180-181. doi:10.5935/abc .20180146.
    1. Maccarone MC, Magro G, Solimene U, Scanu A, Masiero S. From in vitro research to real life studies: an extensive narrative review of the effects of balneotherapy on human immune response. Sport Sci Health. 2021. May 20:1-19. doi: 10.1007/s11332-021-00778-z. Epub ahead of print..
    1. Masiero S, Maccarone MC, Magro G. Balneotherapy and human immune function in the era of COVID-19. Int J Biometeorol. 2020; 64, 1433–1434. doi:10.1007/s00484-020-01914-z.
    1. Masiero S, Maccarone MC. Health resort therapy interventions in the COVID-19 pandemic era: what next?. Int J Biometeorol. 2021. doi:10.1007/s00484-021-02134-9.
    1. Gálvez I, Torres-Piles S, Ortega-Rincón E. Balneotherapy immune system stress response: a hormetic strategy? Int J Mol Sci. 2018; 19(6):1687. doi:10.3390/ijms19061687.
    1. Bhasin MK, Denninger JW, Huffman JC, Joseph MG, Niles H, Chad-Friedman E, Goldman R, Buczynski-Kelley B, Mahoney BA, Fricchione GL, Dusek JA, Benson H, Zusman RM, Libermann TA. Specific Transcriptome Changes Associated with Blood Pressure Reduction in Hypertensive Patients After Relaxation Response Training. J Altern Complement Med. 2018. May;24(5):486-504. doi: 10.1089/acm.2017.0053. Epub 2018 Apr 4.
    1. Ramos RA, Guimarães FS, Dionyssiotis Y, Tsekoura D, Papathanasiou J, Ferreira AS. Development of a multivariate model of the six-minute walked distance to predict functional exercise capacity in hypertension. J Bodyw Mov Ther. 2019;23(1):32-38. doi:10.1016/j.jbmt.2018 .01.010.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi